Compare Galaxy Digital Inc. Class A Common Stock (GLXY) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Galaxy Digital Inc. Class A Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? Galaxy Digital Inc. Class A Common Stock trades at $20.36 (market cap $3.90B), while Relay Therapeutics Inc. Common Stock trades at $17.89 (market cap $3.82B). The key difference: Galaxy Digital Inc. Class A Common Stock and Relay Therapeutics Inc. Common Stock are close in size by market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Galaxy Digital Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Galaxy Digital Inc. Class A Common Stock for 1 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| GLXY | RLAY | |
|---|---|---|
Market Cap | $3.90B | $3.82B |
Volume | 7,887,173 | 4,332,079 |
Sector | Financials | Health |
52-Week High | $42.86 | $20.75 |
52-Week Low | $16.84 | $6.03 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $6.36B | $2.93B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Galaxy Digital Inc. Class A Common Stock
Galaxy provides digital-asset financial services and data center infrastructure. Its digital-assets business includes trading, asset management, investment banking, staking, tokenization, and custody technology.
Read more on GLXY →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
